IP Library Assignment 032409/0691
Patent Assignment
Reel/Frame 032409/0691

Assignment of Assignor's Interest

Recorded: 2014-03-11 Pages: 3
Assignor
MITRA, SOUMYA
Executed: 2012-06-11
Assignee
GILEAD CONNECTICUT, INC.
C/O GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404
Covered Property (1)
6-(1H-Indazol-6-Yl)-N-{4-[2-Methyl-1-(Morpholin-4-Yl)Propan-2-Yl]Phenyl}Imidazo[1,2-A]Pyrazin-8-Amine, or a Pharmaceutically Acceptable Salt Thereof, as a Syk Inhibitor
Patent: 8,765,761 →
Application: 13/868,967 →
Publication: US 2013/0237520
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 11, 2014
From: MITCHELL, SCOTT A.; CURRIE, KEVIN S.; BLOMGREN, PETER A.; KROPF, JEFFREY E.
To: CGI PHARMACEUTICALS, INC.
Reel/Frame 032409/0530 →
Assignment of Assignor's Interest Mar 11, 2014
From: BARBOSA, ANTONIO J., JR.; ZHAO, ZHONGDONG
To: CGI PHARMACEUTICALS, INC.
Reel/Frame 032409/0546 →
Merger Mar 11, 2014
From: CGI PHARMACEUTICALS, INC.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 032409/0581 →
Assignment of Assignor's Interest Mar 11, 2014
From: ARMISTEAD, DAVID M.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 032409/0684 →
Merger and Change of Name Sep 17, 2020
From: COUGAR MERGER SUB, INC.; CGI PHARMACEUTICALS, INC.; CGI PHARMACEUTICALS, INC.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 053799/0190 →
Assignment of Assignor's Interest Sep 30, 2020
From: GILEAD CONNECTICUT, INC.
To: KRONOS BIO, INC.
Reel/Frame 053927/0969 →